Reducing the risk of metastatic relapse in patients with resectable soft tissue sarcomas is crucial for improving outcomes, because metastasis is the primary cause of mortality in this population.
Systemic rheumatic diseases, the immunomodulatory medications used to treat them, and the comorbidities associated with them, might predispose individuals to these syndromes. This Series in The Lancet ...
As we enter London Global Cancer Week (Nov 11–15, 2024), cancer care is at a crucial juncture in the UK. Although cancer survival in the UK has improved in the past 50 years, it is still worse than ...
Tremendous successes have been achieved in treating and caring for people living with HIV and in developing HIV prevention technologies such as pre-exposure prophylaxis (PrEP) and post-exposure ...
Welcome to the Lancet Global Burden of Disease (GBD) Resource Centre, bringing together the most comprehensive data and analysis of worldwide trends in global health, published across the Lancet ...
Progress of COVID-19 vaccination programmes for older adults is uneven across countries, emphasising an ongoing challenge to achieve vaccine equity for this high-risk age group. Therefore, it is ...